Richette P, Doherty M, Pascual E, et al. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout [J]. Ann Rheum Dis, 2020, 79(1): 31-38.
[5]
Neogi T, Jansen T L, Dalbeth N, et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative [J]. Ann Rheum Dis, 2015, 74(10): 1789-1798.
Stewart S, Maxwell H, Dalbeth N. Prevalence and discrimination of OMERACT -defined elementary ultrasound lesions of gout in people with asymptomatic hyperuricemia: a systematic review and meta -analysis[J]. Semin Arthritis Rheum, 2019, 49: 62-73.
Christiansen S N, Ostergaard M, Slot O, et al. Assessing the sensitivity to change of the OMERACT ultrasound structural gout lesions during urate-lowering therapy [J]. RMD Open, 2020, 6: e001144-e001152.
[18]
Zou Z, Yang M, Wang Y, et al. Association of urate deposition shown by ultrasound and frequent gout attacks [J]. Z Rheumatol, 2021, 80(6): 565-569.
[19]
Hammer H B, Karoliussen L, Terslev L, et al. Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study [J]. Ann Rheum Dis, 2020,79:1500-1505.
Wang M,Feng H L,Liu Y Q,et al. Angiogenesis research in mouse mammary cancer based on contrast-enhanced ultrasonography:exploratory study[J]. Acad Radiol, 2018, 25(7):889-897.
2025, Vol. 36 
